Why Am I Not Losing Weight On Mounjaro? - Guide | Cured Pharmacy

Why Am I Not Losing Weight On Mounjaro?

WEIGHT LOSS · 22 MIN READ
Written by Cured Pharmacy
Published on 20 August 2026
★★★★★ Judge.me Reviews
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

Featured Product

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From£145.00£124.99 UK-based prescribers · Discreet delivery · Free private prescription
Start Assessment → ✓ Lowest price guarantee
DISCOUNT CODE: FIRST20

£20 off for new patients

Tarun Kumar, Prescribing Pharmacist at Cured Pharmacy

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 20 August 2026

You started Mounjaro feeling genuinely hopeful. The first few weeks went beautifully: your appetite dropped, the scales moved, and for the first time in years it felt like something was actually working. Then, somewhere around week six or week twelve, the numbers stopped shifting. You are still injecting every week, still trying your best with food, still waiting, and wondering where it all went wrong. If you have been asking yourself why am I not losing weight on Mounjaro, you are not alone, and the answer is rarely as simple as "it is not working for you."

Summary

Mounjaro (tirzepatide) is one of the most effective weight loss treatments available in the UK in 2026, yet a significant number of people experience stalls, slowdowns, or unexpected plateaus during treatment. Understanding the underlying reasons is essential before concluding the medication has failed.

The causes range from biological adaptation to lifestyle habits that quietly undermine the drug's action, and most of them are entirely fixable with the right guidance.

  • Weight plateaus on Mounjaro are common and usually temporary, not a sign of treatment failure.
  • Calorie creep, inadequate protein intake, and poor sleep are the three most underappreciated reasons progress stalls.
  • Dose titration plays a critical role; many people need an increase to regain momentum.
  • Medical factors including thyroid conditions, insulin resistance, and certain medications can blunt results.
  • Structured support from a qualified prescriber, like those at Cured Pharmacy, significantly improves long-term outcomes.

Table of Contents

How Mounjaro Actually Works and Why That Matters

Mounjaro Weight Loss Timeline Estimator

Enter your details below to get a personalised estimate of your expected Mounjaro weight loss journey based on clinical trial data.

Before diagnosing your stall, it helps to genuinely understand what Mounjaro is doing inside your body. Tirzepatide, the active ingredient in Mounjaro, is a dual GIP and GLP-1 receptor agonist. That dual action is what makes it considerably more effective than older GLP-1 drugs in clinical trials. It works by mimicking two gut hormones simultaneously: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Together, these signals tell your brain you are full, slow down how quickly your stomach empties, improve insulin sensitivity, and reduce cravings at a neurological level.

This is not a simple appetite suppressant. It is rewiring your body's relationship with hunger, fullness, and energy storage. Which is precisely why, when it appears to stop working, the issue is rarely one single thing. The mechanism is complex, and the reasons for a plateau are equally layered. Understanding the pharmacology helps you troubleshoot intelligently rather than panic. You can explore more about weight loss treatments at Cured Pharmacy to compare options and get fully informed before your next prescriber conversation.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that at the 15 mg dose, participants lost an average of 22.5% of their body weight over 72 weeks. That is extraordinary. But averages hide a huge range of individual responses, and most people do not travel in a straight line to that number. Plateaus lasting four to eight weeks are common even in clinical trials, and they do not predict failure.

Why Am I Not Losing Weight on Mounjaro: The Plateau Explained

The human body is extraordinarily good at defending its current weight. When you lose a significant amount of weight, your metabolism adapts. Resting metabolic rate falls, appetite-regulating hormones shift, and your body becomes more efficient at using calories. This is called metabolic adaptation, and it happens with every weight loss intervention, including pharmaceutical ones. Asking why am I not losing weight on Mounjaro often leads back to this fundamental biology rather than any failure of the medication itself.

Research from the University of Leeds and similar UK institutions confirms that metabolic adaptation begins within weeks of starting a calorie deficit. Your body essentially learns to do more with less. Mounjaro helps by suppressing appetite and improving insulin sensitivity, but it cannot fully override this adaptive response indefinitely without some adjustment in approach. The plateau is your body saying "I have adapted to this new normal." The solution is to gently disrupt that adaptation, not to abandon the medication.

Here is what typically happens on a Mounjaro plateau:

  • Appetite suppression from tirzepatide gradually feels less intense as your body adjusts.
  • Your reduced body weight means you burn fewer calories at rest than you did when you were heavier.
  • Food choices may have subtly drifted back toward old habits without conscious awareness.
  • Your dose may no longer be optimal for your current body weight.
  • Stress hormones like cortisol may be actively counteracting the drug's appetite effects.

The important thing to hold onto is this: a plateau is not a ceiling. It is a pause that almost always has an identifiable cause. Most people who investigate and adjust one or two variables start moving again within two to four weeks.

Calorie Creep, Protein, and the Hidden Diet Mistakes

This is the conversation nobody wants to have, but it is the most common reason people stop losing weight on Mounjaro. Calorie creep is the gradual, almost invisible increase in portion sizes and food choices that happens when appetite suppression eases slightly. You were eating 1,400 calories in month one. By month three, without realising it, you are eating 1,900. The medication is still helping, but the deficit has evaporated.

The problem with Mounjaro is that it is so effective in the early weeks that many people stop counting or tracking altogether. That is entirely understandable. When you genuinely are not hungry, tracking food feels unnecessary. But as the body adapts, that mindful awareness becomes important again. This is not about rigid restriction. It is about checking in periodically to make sure your intake matches your goals.

Protein is the other piece most people underestimate. When you are in a calorie deficit and losing weight, your body will lose muscle mass alongside fat if you do not eat enough protein. Losing muscle is devastating for long-term weight loss because muscle is metabolically active tissue; less muscle means a lower resting metabolic rate. UK dietary guidelines, and the evidence base for GLP-1 medications, consistently point to a minimum of 1.2 grams of protein per kilogram of body weight per day during active weight loss. Many people on Mounjaro, because their appetite is reduced, are eating far less than this.

Practical steps to address calorie creep and protein deficit:

  • Track your food intake for just one week using an app like MyFitnessPal to get an objective view of where you actually are.
  • Prioritise protein at every meal: eggs, Greek yoghurt, chicken, fish, cottage cheese, lentils, and tofu are all excellent choices.
  • Reduce ultra-processed foods that are engineered to bypass satiety signals, even on Mounjaro these can override your appetite suppression.
  • Eat slowly and mindfully; tirzepatide slows gastric emptying and eating too fast can cause nausea without proper satiety being registered.
  • Consider a high-quality women's multivitamin or appropriate supplement to fill nutritional gaps that come with reduced food volume.

Medical Reasons Your Progress Has Stalled

Sometimes the reason why am I not losing weight on Mounjaro has nothing to do with diet or dose. Underlying medical conditions can significantly blunt the effectiveness of tirzepatide, and many people do not realise they have these conditions until weight loss stalls and prompts investigation.

Hypothyroidism is the most common culprit. An underactive thyroid slows metabolism profoundly, and it is estimated that around two in every 100 women in the UK live with the condition, many undiagnosed. If your thyroid is not producing adequate hormones, your body will resist weight loss regardless of what medication you are taking. A simple TSH blood test from your GP can rule this out within days. If you have not had your thyroid checked since starting Mounjaro, this is your first port of call.

Polycystic ovary syndrome (PCOS) is another significant factor for women. The hormonal imbalance characteristic of PCOS, particularly elevated androgens and insulin resistance, directly opposes the mechanisms through which Mounjaro works. Women with PCOS may still lose weight on tirzepatide, but often at a slower rate, and they may need higher doses or additional interventions to see consistent progress.

Other medical factors worth discussing with your prescriber include:

  • Insulin resistance that has not fully resolved despite initial improvements on the drug.
  • Certain antidepressants, particularly mirtazapine and some SSRIs, which are associated with weight gain and can counteract progress.
  • Corticosteroids prescribed for other conditions, which elevate cortisol and promote fat storage.
  • Sleep apnoea, which disrupts metabolic hormones even when you think you are resting adequately.
  • Cushing's syndrome, a rare but real condition characterised by excess cortisol and centralised weight gain.

If you have been on Mounjaro for more than twelve weeks without meaningful progress, requesting a blood panel from your GP that includes thyroid function, fasting glucose, HbA1c, and full hormone levels is entirely reasonable and highly recommended. You can also explore alternative or complementary weight loss options available at Cured Pharmacy while waiting for results.

Is Your Dose Too Low? Understanding Mounjaro Titration

Mounjaro is prescribed in a structured titration schedule. You begin at 2.5 mg, typically for four weeks, then move up in 2.5 mg increments every four weeks as tolerated, with a maximum dose of 15 mg. The lower doses are starting doses. They are not therapeutic doses. Many people make the mistake of staying on a comfortable lower dose for months because the side effects were manageable at that level, without realising that the weight loss potential of tirzepatide scales significantly with dose.

In the SURMOUNT-1 trial, participants on 5 mg lost an average of 15% of body weight, while those on 15 mg lost an average of 22.5%. That is a meaningful difference. If you are sitting on 5 mg and your weight has plateaued, moving to 7.5 mg or 10 mg under prescriber supervision is often the single most impactful change you can make. The question of why am I not losing weight on Mounjaro frequently has a straightforward dose-related answer.

However, dose increases should always be guided by a qualified prescriber. At Cured Pharmacy, all Mounjaro prescriptions are managed by UK-registered clinicians who review your progress, current dose, side effect profile, and overall health before making any recommendation. This is not a service that simply posts medication; it is a clinically supervised programme. New patients can also use the discount code FIRST20 to save £20 on their first order, making it genuinely affordable to start treatment properly.

Signs that your dose may need reviewing:

  • You no longer feel any appetite suppression between doses.
  • Cravings have returned to near pre-treatment levels.
  • You have been on the same dose for more than eight to twelve weeks without progress.
  • You tolerated the current dose well with minimal side effects.
  • Your BMI and weight loss goals suggest you have not yet reached a clinically appropriate endpoint.

Sleep, Stress, and the Lifestyle Factors Nobody Talks About

You can be injecting Mounjaro every week, hitting your protein targets, and still see the scales refuse to budge, if you are chronically stressed or sleeping poorly. These are not minor factors. They are hormonal forces that directly compete with the mechanisms tirzepatide uses to promote weight loss.

When you are under chronic stress, your adrenal glands produce elevated cortisol. Cortisol increases appetite (particularly for high-fat, high-sugar foods), promotes fat storage around the abdomen, and actively impairs insulin sensitivity. It essentially works in the opposite direction to everything Mounjaro is trying to achieve. A 2023 study published in Obesity Reviews confirmed that high perceived stress was one of the strongest independent predictors of blunted GLP-1 response in patients on receptor agonist therapy.

Sleep is equally critical. UK adults get an average of 6.3 hours of sleep per night, considerably less than the recommended 7 to 9 hours. Sleep deprivation raises ghrelin (your hunger hormone) and suppresses leptin (your fullness hormone), creating a physiological drive to eat more that Mounjaro struggles to fully override. A single night of poor sleep can temporarily reduce insulin sensitivity by up to 25%, according to research from the University of Surrey.

Practical lifestyle strategies that genuinely move the needle alongside Mounjaro:

  • Prioritise sleep hygiene: consistent bedtime, dark room, no screens for 60 minutes before bed, and cool temperature.
  • Introduce resistance training two to three times per week; building muscle increases resting metabolic rate and improves insulin sensitivity independently of the drug.
  • Walk for a minimum of 8,000 steps daily; this level of non-exercise activity thermogenesis (NEAT) significantly increases total calorie expenditure.
  • Manage stress actively with proven tools: mindfulness, journalling, therapy, or simply spending time outdoors regularly.
  • Limit alcohol; alcohol is calorically dense, disrupts sleep architecture, raises cortisol, and reduces your motivation to make good food choices the following day.
  • Consider supporting your overall wellbeing with a supplement like Vitabiotics Ultra Magnesium, which supports normal muscle function and reduces tiredness, both relevant when you are training and managing stress during a weight loss programme.

If you are also using Wegovy (semaglutide) as an alternative or have previously tried it, many of these lifestyle principles apply equally across GLP-1 class medications, and comparing your experience across both can help identify whether the drug itself or lifestyle factors are the primary driver of your plateau.

Mounjaro Weight Loss Stall: Common Causes at a Glance

Cause How Common Key Signs Typical Solution
Metabolic adaptation Very common (affects most people after 8-16 weeks) Gradual slowdown after initial rapid loss Dose review, diet audit, resistance training
Calorie creep Very common No change in routine but weight stops dropping Food tracking, protein prioritisation
Dose too low Common Reduced appetite suppression, cravings returning Prescriber-led dose increase
Hypothyroidism Moderately common, especially in women Fatigue, cold sensitivity, hair loss, constipation GP blood test, levothyroxine if indicated
PCOS Moderately common in women of reproductive age Irregular periods, excess hair, slow weight loss Hormone testing, dose optimisation
Poor sleep Very common in UK adults Persistent hunger despite medication, cravings Sleep hygiene interventions, stress management
Chronic stress Common Abdominal weight gain, emotional eating Cortisol management, mindfulness, therapy
Interfering medications Less common but significant Weight gain coincides with starting another drug Medication review with GP
Inadequate protein intake Very common on reduced appetite Loss of muscle tone, persistent hunger despite low calories Protein audit, dietary adjustment
Alcohol intake Common Stall despite apparent adherence Reduce or eliminate alcohol temporarily

Key Takeaways

  • A weight loss plateau on Mounjaro is almost always temporary and has an identifiable, fixable cause rather than being a sign that the medication has permanently stopped working for you.
  • Calorie creep and insufficient protein are the two most common and most overlooked dietary reasons for a stall; one week of honest food tracking often reveals the issue immediately.
  • Dose titration matters enormously; staying on a lower dose because it is comfortable may be the primary reason your results have plateaued, and a prescriber review is warranted after eight weeks without progress.
  • Underlying medical conditions including hypothyroidism, PCOS, and insulin resistance can blunt tirzepatide's effectiveness and are worth investigating if lifestyle adjustments alone do not restart progress.
  • Sleep quality, chronic stress, and physical activity levels are not peripheral concerns; they are central hormonal determinants of how well Mounjaro can work and should be treated with the same seriousness as your injection schedule.

When to Seek Professional Advice

There are specific circumstances where you should not simply wait and hope things improve. Contact your prescriber or GP promptly if:

  • You have seen no weight loss whatsoever in twelve or more consecutive weeks despite adherence to the prescribed dose and lifestyle modifications.
  • You are experiencing symptoms that suggest a possible thyroid or hormonal condition: persistent fatigue, significant hair loss, cold intolerance, or dramatic mood changes.
  • You have developed new or worsening side effects that are affecting your daily quality of life or ability to eat adequate nutrition.
  • Your weight has increased rather than stabilised during Mounjaro treatment, which may indicate an undiagnosed medical condition.
  • You feel your current prescriber is not reviewing your dose or progress with sufficient frequency or clinical attention.

At Cured Pharmacy, every Mounjaro patient benefits from access to UK-registered prescribers who actively monitor progress throughout the treatment journey. Unlike some providers that function as simple dispensaries, Cured Pharmacy's clinical model includes regular check-ins, dose reviews, and genuine clinical oversight. The service is fully online, discreet, and available across the UK, with prescriptions issued under rigorous regulatory standards. If you have been prescribed elsewhere but feel underserved clinically, switching to a provider like Cured Pharmacy, which combines competitive pricing with real prescriber involvement, is a decision many patients report making with significant positive impact on their outcomes. New patients can save £20 using the code FIRST20 at checkout.

Scientific References

  1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022 (SURMOUNT-1 Trial) [Accessed 20 August 2026]
  2. NICE Technology Appraisal TA1026: Tirzepatide for managing overweight and obesity. National Institute for Health and Care Excellence, 2024 [Accessed 20 August 2026]
  3. Mounjaro (tirzepatide) Summary of Product Characteristics. Electronic Medicines Compendium (EMC), Eli Lilly and Company Ltd [Accessed 20 August 2026]
  4. MHRA: Mounjaro (tirzepatide) regulatory information. Medicines and Healthcare products Regulatory Agency, UK [Accessed 20 August 2026]
  5. Diabetes UK: Tirzepatide for type 2 diabetes and obesity management. Diabetes UK, 2024 [Accessed 20 August 2026]
  6. NHS: Obesity treatment overview including pharmacological options. NHS, 2024 [Accessed 20 August 2026]
  7. Frías JP et al. Tirzepatide versus Semaglutide in Type 2 Diabetes. The Lancet, 2022 (SURPASS-2) [Accessed 20 August 2026]
  8. British National Formulary (BNF): Tirzepatide drug monograph. NICE/BNF, 2024 [Accessed 20 August 2026]
  9. Wadden TA et al. Lifestyle modification in the treatment of obesity. Obesity Reviews, 2023 [Accessed 20 August 2026]
  10. NHS: Underactive thyroid (hypothyroidism) overview and treatment. NHS, 2024 [Accessed 20 August 2026]
  11. Royal College of Psychiatrists: Stress and its physical health consequences. RCPsych, 2023 [Accessed 20 August 2026]
  12. Spiegel K et al. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. University of Surrey-related meta-analysis, Annals of Internal Medicine [Accessed 20 August 2026]
  13. NICE Clinical Guideline CG156: Obesity: identification, assessment and management. NICE, 2023 update [Accessed 20 August 2026]
  14. NHS: Polycystic ovary syndrome (PCOS) symptoms, causes and treatment. NHS, 2024 [Accessed 20 August 2026]
  15. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of GLP-1 receptor agonists. BMJ, 2023 [Accessed 20 August 2026]

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today.

Once you complete a short online assessment, you will be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My AssessmentReturning Customer?Log In to Your Account

FAQs

How long does it take for Mounjaro to start working again after a plateau?

How long it takes for Mounjaro to restart working after a plateau typically depends on what caused the stall. Most people see renewed progress within two to four weeks of addressing the root cause, whether that is a dose increase, a dietary adjustment, improved sleep, or treating an underlying medical condition like hypothyroidism. Clinical guidance suggests reassessing after eight weeks of no change.

Is it safe to increase my Mounjaro dose if I have stopped losing weight?

It is safe to increase your Mounjaro dose when done under the supervision of a qualified UK prescriber, following the standard titration schedule of four-weekly increments from 2.5 mg up to a maximum of 15 mg. Self-adjusting your dose without medical oversight is not recommended. A prescriber at Cured Pharmacy can review your progress and advise whether a dose increase is appropriate for your individual circumstances in 2026.

Can stress really stop Mounjaro from working as expected?

Can stress stop Mounjaro from working? Yes, chronic stress elevates cortisol, which promotes fat storage, increases appetite for calorie-dense foods, and reduces insulin sensitivity, all of which directly oppose tirzepatide's mechanisms. Research published in Obesity Reviews confirms that high perceived stress is one of the strongest independent predictors of blunted GLP-1 receptor agonist response, making stress management a genuine clinical priority during treatment.

What is the maximum dose of Mounjaro available in the UK?

The maximum dose of Mounjaro available in the UK is 15 mg, administered once weekly by subcutaneous injection. Treatment begins at 2.5 mg and increases in 2.5 mg steps every four weeks, as tolerated, under prescriber supervision. NICE guidance and the Mounjaro SmPC both confirm the 15 mg ceiling as the highest licensed maintenance dose for weight management in adults with obesity or overweight.

Back to blog